This report analyzed the patient acceptance rate and reported outcomes when a pharmacist provided interventions for patients on oral targeted breast cancer therapies in a mail order integrated health system specialty pharmacy.
This report explores the background of 340B covered entities, how they operate and the ways Lumicera’s clinical liaison team optimizes these programs for cost savings.
This study presents an analysis of the methods and outcomes of patient engagement strategies for biosimilar adoption within a specialty pharmacy setting.
This whitepaper presents a study highlighting the transformative impact of an automated patient engagement service utilizing SMS and email.
